Can high-dose omega-3 fatty acids and high-dose vitamin D3 (cholecalciferol) prevent type 1 diabetes and sustain preservation of beta-cell function after disease onset?
作者信息
Ricordi C, Lanzoni G
机构信息
Diabetes Research Institute, Clinical Cell Transplant Program, University of Miami, Miami, FL, USA.
ISMETT, Palermo, Italy.
出版信息
CellR4 Repair Replace Regen Reprogram. 2018;6(1). Epub 2018 Mar 19.
Abstract
摘要
相似文献
1
Can high-dose omega-3 fatty acids and high-dose vitamin D3 (cholecalciferol) prevent type 1 diabetes and sustain preservation of beta-cell function after disease onset?
CellR4 Repair Replace Regen Reprogram. 2018;6(1). Epub 2018 Mar 19.
2
Combination high-dose omega-3 fatty acids and high-dose cholecalciferol in new onset type 1 diabetes: a potential role in preservation of beta-cell mass.
Eur Rev Med Pharmacol Sci. 2016 Jul;20(15):3313-8.
3
Vitamin D and omega-3 trial to prevent and treat diabetic kidney disease: Rationale, design, and baseline characteristics.
Contemp Clin Trials. 2018 Nov;74:11-17. doi: 10.1016/j.cct.2018.09.014. Epub 2018 Sep 30.
4
Randomized Study of the Effect of Vitamin D and Omega-3 Fatty Acids Cosupplementation as Adjuvant Chemotherapy on Inflammation and Nutritional Status in Colorectal Cancer Patients.
J Diet Suppl. 2020;17(4):384-400. doi: 10.1080/19390211.2019.1600096. Epub 2019 May 20.
5
Low-Dose Omega-3 Fatty Acid and Vitamin D for Anthropometric, Biochemical Blood Indices and Respiratory Function. Does it work?
Int J Vitam Nutr Res. 2020 Jan;90(1-2):67-83. doi: 10.1024/0300-9831/a000476. Epub 2019 Apr 1.
6
POSEIDON study: a pilot, safety and feasibility trial of high-dose omega3 fatty acids and high-dose cholecalciferol supplementation in type 1 diabetes.
CellR4 Repair Replace Regen Reprogram. 2018;6(1). Epub 2018 Mar 19.
7
Randomized Study Design to Test Effects of Vitamin D and Omega-3 Fatty Acid Supplementation as Adjuvant Therapy in Colorectal Cancer Patients.
Methods Mol Biol. 2020;2138:337-350. doi: 10.1007/978-1-0716-0471-7_24.
8
Combined Treatment with Omega-3 Fatty Acid and Cholecalciferol Increases 1,25-Dihydroxyvitamin D Levels by Modulating Dysregulation of Vitamin D Metabolism in 5/6 Nephrectomy Rats.
Nutrients. 2019 Dec 1;11(12):2903. doi: 10.3390/nu11122903.
9
Lung VITAL: Rationale, design, and baseline characteristics of an ancillary study evaluating the effects of vitamin D and/or marine omega-3 fatty acid supplements on acute exacerbations of chronic respiratory disease, asthma control, pneumonia and lung function in adults.
Contemp Clin Trials. 2016 Mar;47:185-95. doi: 10.1016/j.cct.2016.01.003. Epub 2016 Jan 16.
10
Effect of cholecalciferol as adjunctive therapy with insulin on protective immunologic profile and decline of residual β-cell function in new-onset type 1 diabetes mellitus.
Arch Pediatr Adolesc Med. 2012 Jul 1;166(7):601-7. doi: 10.1001/archpediatrics.2012.164.
引用本文的文献
1
Vitamin D Repletion and AA/EPA Intake in Children with Type 1 Diabetes: Influences on Metabolic Status.
Nutrients. 2022 Nov 1;14(21):4603. doi: 10.3390/nu14214603.
2
Vitamin D and Omega 3 Field Study on Progression of Type 1 Diabetes.
CellR4 Repair Replace Regen Reprogram. 2019;7. doi: 10.32113/cellr4_20198_2737. Epub 2019 Aug 28.
本文引用的文献
1
Administration of vitamin D and high dose of omega 3 to sustain remission of type 1 diabetes.
Eur Rev Med Pharmacol Sci. 2018 Jan;22(2):512-515. doi: 10.26355/eurrev_201801_14203.
2
Can Type 1 diabetes progression be halted? Possible role of high dose vitamin D and omega 3 fatty acids.
Eur Rev Med Pharmacol Sci. 2017 Apr;21(7):1604-1609.
3
ω-3 polyunsaturated fatty acids ameliorate type 1 diabetes and autoimmunity.
J Clin Invest. 2017 May 1;127(5):1757-1771. doi: 10.1172/JCI87388. Epub 2017 Apr 4.
4
Vitamin D: not just the bone. Evidence for beneficial pleiotropic extraskeletal effects.
Eat Weight Disord. 2017 Mar;22(1):27-41. doi: 10.1007/s40519-016-0312-6. Epub 2016 Aug 23.
5
Combination high-dose omega-3 fatty acids and high-dose cholecalciferol in new onset type 1 diabetes: a potential role in preservation of beta-cell mass.
Eur Rev Med Pharmacol Sci. 2016 Jul;20(15):3313-8.
6
Fasting plasma C-peptide and micro- and macrovascular complications in a large clinic-based cohort of type 1 diabetic patients.
Diabetes Care. 2009 Feb;32(2):301-5. doi: 10.2337/dc08-1241. Epub 2008 Nov 18.
7
C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat.
Diabetologia. 2001 Jul;44(7):889-97. doi: 10.1007/s001250100570.
8
The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients.
Diabetologia. 1992 Feb;35(2):121-8. doi: 10.1007/BF00402543.
9
Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulin-dependent) diabetic patients.
Diabetologia. 1992 Dec;35(12):1151-8. doi: 10.1007/BF00401369.
Zotero 插件